Newbridge Financial Services Group’s Avanos Medical AVNS Stock Holding History

Newbridge Financial Services Group’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$299	Hold	12	–	–	﹤0.01%	1172
2026 Q1	$168	Hold	12	–	–	﹤0.01%	1134
2025 Q4	$135	Hold	12	–	–	﹤0.01%	1144
2025 Q3	$139	Hold	12	–	–	﹤0.01%	1254
2025 Q2	$147	Hold	12	–	–	﹤0.01%	1273
2025 Q1	$172	Sell	12 -49	-80%	-$765	﹤0.01%	1001
2024 Q4	$971	Buy	61 +49	+408%	+$970	﹤0.01%	1021
2024 Q3	$288	Hold	12	–	–	﹤0.01%	625
2024 Q2	$239	Hold	12	–	–	﹤0.01%	1040
2024 Q1	$239	Hold	12	–	–	﹤0.01%	1118
2023 Q4	$269	Hold	12	–	–	﹤0.01%	1069
2023 Q3	$243	Hold	12	–	–	﹤0.01%	1234
2023 Q2	$307	Hold	12	–	–	﹤0.01%	1278
2023 Q1	$357	Hold	12	–	–	﹤0.01%	1336
2022 Q4	$325	Hold	12	–	–	﹤0.01%	1374
2022 Q3	$0	Hold	12	–	–	﹤0.01%	1381
2022 Q2	$0	Hold	12	–	–	﹤0.01%	1361
2022 Q1	$0	Hold	12	–	–	﹤0.01%	1436
2021 Q4	$0	Hold	12	–	–	﹤0.01%	1413
2021 Q3	$1K	Hold	12	–	–	﹤0.01%	1223
2021 Q2	$0	Hold	12	–	–	﹤0.01%	1431
2021 Q1	$1K	Hold	12	–	–	﹤0.01%	1231
2020 Q4	$1K	Hold	12	–	–	﹤0.01%	1004
2020 Q3	$0	Buy	+12	New	+$383	﹤0.01%	1028

Other funds holding AVNS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Newbridge Financial Services Group's AVNS Position: Q2 2026 in Review

Newbridge Financial Services Group held its Avanos Medical (AVNS) position steady in Q2 2026 at 12 shares worth $299. The position accounts for ﹤0.01% of the portfolio, ranked #1172.

Newbridge Financial Services Group first reported a position in AVNS in Q3 2020 and has held it in 24 quarters since. The position peaked at $1K in Q3 2021. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

Newbridge Financial Services Group held 12 shares of Avanos Medical worth $299 as of Q2 2026.
Newbridge Financial Services Group left its Avanos Medical share count unchanged in Q2 2026.
Avanos Medical made up ﹤0.01% of Newbridge Financial Services Group's portfolio in Q2 2026, its #1172 holding.
Newbridge Financial Services Group first reported a position in Avanos Medical in Q3 2020 and has held it in 24 quarters since.
Newbridge Financial Services Group's Avanos Medical position peaked at $1K in Q3 2021.
286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Newbridge Financial Services Group's 13F filing for Q2 2026, filed 14 Aug 2026.